1,113
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of the virulence and transmissibility of canine H3N2 influenza viruses and characterization of their canine adaptation factors

, , , , , , , , , & show all
Pages 1-14 | Received 09 Aug 2017, Accepted 14 Dec 2017, Published online: 07 Mar 2018

Figures & data

List of H3N2 viruses isolated from canines in South Korea from 2009 to 2013

Amino acid sequence comparison between virus isolates

Fig. 1 Schematic diagram of commonly divergent amino acids of each gene segment in CIVs from 2007 to 2013 canine isolates.

Differences in the amino acid residues of each gene are indicated by single-letter amino acid codes with positions indicated at the top of the diagram. The black and white letters indicate the amino acid regions originating from the first Korean CIV and recent CIVs, respectively. The amino acid positions of HA are based on the numbering of the H3 HA. Type I includes only one A/canine/Korea/AS-01/2009 virus. Three individual isolates (AS-05/12, AS-08/12, and AS-09/12 viruses) comprise Type II viruses. Type III viruses were the most divergent viruses from the Type I virus, containing six individual isolates (AS-03/12, AS-04/12, AS-06/12, AS-11/13, AS-14/13, and AS-15/13 viruses)

Fig. 1 Schematic diagram of commonly divergent amino acids of each gene segment in CIVs from 2007 to 2013 canine isolates.Differences in the amino acid residues of each gene are indicated by single-letter amino acid codes with positions indicated at the top of the diagram. The black and white letters indicate the amino acid regions originating from the first Korean CIV and recent CIVs, respectively. The amino acid positions of HA are based on the numbering of the H3 HA. Type I includes only one A/canine/Korea/AS-01/2009 virus. Three individual isolates (AS-05/12, AS-08/12, and AS-09/12 viruses) comprise Type II viruses. Type III viruses were the most divergent viruses from the Type I virus, containing six individual isolates (AS-03/12, AS-04/12, AS-06/12, AS-11/13, AS-14/13, and AS-15/13 viruses)
Fig. 2 Pathogenicity and transmissibility of AS-01/09, AS-05/12, AS-11/13, and LPM91/2006 viruses in beagles.

The body temperatures of infected (a) and contact (b) beagles (†succumbed to death) were monitored. Groups of four beagles inoculated with 105.5 EID50 of each virus were individually placed adjacent to naïve (contact) beagles. The mean viral titers (log10 EID50/mL) for nasal-wash (c) or lung and tracheal (d) samples are shown for each group of beagles. The limit of virus detection was 0.7 log10 EID50/mL or gram. Statistically significant differences (*P < 0.05, **P < 0.001, and ***P < 0.0001) between each representative canine and AS-01/09 viruses are indicated by *P value was determined using one-way ANOVA

Fig. 2 Pathogenicity and transmissibility of AS-01/09, AS-05/12, AS-11/13, and LPM91/2006 viruses in beagles.The body temperatures of infected (a) and contact (b) beagles (†succumbed to death) were monitored. Groups of four beagles inoculated with 105.5 EID50 of each virus were individually placed adjacent to naïve (contact) beagles. The mean viral titers (log10 EID50/mL) for nasal-wash (c) or lung and tracheal (d) samples are shown for each group of beagles. The limit of virus detection was 0.7 log10 EID50/mL or gram. Statistically significant differences (*P < 0.05, **P < 0.001, and ***P < 0.0001) between each representative canine and AS-01/09 viruses are indicated by *P value was determined using one-way ANOVA
Fig. 3 In vitro characterization of each representative type of canine influenza virus (AS-01/09, AS-05/12, and AS-11/13) and their ancestor virus (LPM91/06) in mammalian cell lines.

Each virus was infected at an MOI of 0.001 in MDCK cells (a) or 0.01 in NHBE cells (b) in the presence of L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin. Supernatants of virus cultured cell lines were harvested at 12, 24, 48, and 72 hpi, and virus titers were measured in MDCK cells. The virus titers were determined as means ± SD from three independently performed experiments. Dotted lines indicate the limit of detection (1.8log10TCID50/mL). Statistically significant differences (*P < 0.05, **P < 0.001, and ***P < 0.0001) between each representative canine and AS-01/09 viruses are indicated by *P value was determined using one-way ANOVA

Fig. 3 In vitro characterization of each representative type of canine influenza virus (AS-01/09, AS-05/12, and AS-11/13) and their ancestor virus (LPM91/06) in mammalian cell lines.Each virus was infected at an MOI of 0.001 in MDCK cells (a) or 0.01 in NHBE cells (b) in the presence of L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin. Supernatants of virus cultured cell lines were harvested at 12, 24, 48, and 72 hpi, and virus titers were measured in MDCK cells. The virus titers were determined as means ± SD from three independently performed experiments. Dotted lines indicate the limit of detection (1.8log10TCID50/mL). Statistically significant differences (*P < 0.05, **P < 0.001, and ***P < 0.0001) between each representative canine and AS-01/09 viruses are indicated by *P value was determined using one-way ANOVA
Fig. 4 Histopathology (a–d) and immunohistochemistry with anti-influenza NP antigen antibody (e–h) of lung samples obtained from ferrets infected with each H3N2 influenza isolate.

Ferrets were intranasally inoculated with 107.0 EID50/mL of each virus. Lungs were harvested 5 days after virus inoculation. LPM91/06 (a and e), AS-01/09 (b and f), AS-05/12 (c and g) and AS-11/13 (d and h), respectively. No damage was evident in lung sections from the LPM91/06-infected group (a and e). Moderate to severe lung damage, indicated by lesions, are shown in the AS-01/09 (b and f), AS-05/12 (c and g) and AS-11/13 (d and h) groups. Arrows indicate positive immunostaining

Fig. 4 Histopathology (a–d) and immunohistochemistry with anti-influenza NP antigen antibody (e–h) of lung samples obtained from ferrets infected with each H3N2 influenza isolate.Ferrets were intranasally inoculated with 107.0 EID50/mL of each virus. Lungs were harvested 5 days after virus inoculation. LPM91/06 (a and e), AS-01/09 (b and f), AS-05/12 (c and g) and AS-11/13 (d and h), respectively. No damage was evident in lung sections from the LPM91/06-infected group (a and e). Moderate to severe lung damage, indicated by lesions, are shown in the AS-01/09 (b and f), AS-05/12 (c and g) and AS-11/13 (d and h) groups. Arrows indicate positive immunostaining

List of canine H3N2 RG viruses in the backbone of the LPM91/06 virus

Fig. 5 Replication and transmission of reassorted viruses in dogs.

Groups of four dogs were inoculated with 105.5 TCID50/mL of each reassorted virus (Table ). RD-contacts were individually placed adjacent to the inoculated dogs at 1 dpi. Nasal wash titers are shown for individual dogs (a and b). Two dogs per group were humanely euthanized at 5 dpi for virus titration in various tissues (c). Virus titers in nasal washes and homogenized tissues are expressed as log10EID50/mL or gram of tissue collected, with the limit of virus detection set at 0.7 log10 EID50/mL or gram

Fig. 5 Replication and transmission of reassorted viruses in dogs.Groups of four dogs were inoculated with 105.5 TCID50/mL of each reassorted virus (Table 3). RD-contacts were individually placed adjacent to the inoculated dogs at 1 dpi. Nasal wash titers are shown for individual dogs (a and b). Two dogs per group were humanely euthanized at 5 dpi for virus titration in various tissues (c). Virus titers in nasal washes and homogenized tissues are expressed as log10EID50/mL or gram of tissue collected, with the limit of virus detection set at 0.7 log10 EID50/mL or gram
Supplemental material

Supplementary Figure S6

Download TIFF Image (9.3 MB)

Supplementary Figure S7

Download TIFF Image (9.3 MB)

Supplementary Figure S8

Download TIFF Image (11.5 MB)

Supplementary Figure S9

Download TIFF Image (9.3 MB)

Supplementary Figure S10

Download TIFF Image (9.3 MB)

Supplementary Figure S11

Download TIFF Image (9.3 MB)

Supplementary Figure S12

Download TIFF Image (4.3 MB)

Supplementary Figure S13

Download TIFF Image (9.3 MB)

Supplementary Figure S14

Download TIFF Image (6.4 MB)

Supplementary Figure S15

Download TIFF Image (16.1 MB)

Supplementary Figure S16

Download MS Word (15 KB)